Denali Therapeutics Inc. (DNLI)
NASDAQ: DNLI · Real-Time Price · USD
14.69
-0.21 (-1.41%)
Jul 3, 2025, 1:00 PM - Market closed
Denali Therapeutics Analyst Ratings
Total Analysts
15
Consensus Rating
Strong Buy
Price Target
$33.85
Upside
+130.43%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| B of A Securities | B of A Securities | Strong Buy Maintains $28 → $27 | Strong Buy | Maintains | $28 → $27 | +83.80% | May 19, 2025 |
| Baird | Baird | Buy Maintains $30 → $29 | Buy | Maintains | $30 → $29 | +97.41% | May 8, 2025 |
| Wedbush | Wedbush | Buy Maintains $32 → $30 | Buy | Maintains | $32 → $30 | +104.22% | May 7, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $80 → $32 | Strong Buy | Maintains | $80 → $32 | +117.84% | May 7, 2025 |
| B of A Securities | B of A Securities | Strong Buy Maintains $30 → $28 | Strong Buy | Maintains | $30 → $28 | +90.61% | Mar 10, 2025 |
| Morgan Stanley | Morgan Stanley | Buy Initiates $41 → $33 | Buy | Initiates | $41 → $33 | +124.64% | Mar 7, 2025 |
| B. Riley Securities | B. Riley Securities | Strong Buy Reiterates $38 → $35 | Strong Buy | Reiterates | $38 → $35 | +138.26% | Mar 5, 2025 |
| Oppenheimer | Oppenheimer | Buy Maintains $50 → $42 | Buy | Maintains | $50 → $42 | +185.91% | Mar 3, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $80 → $87 | Strong Buy | Maintains | $80 → $87 | +492.24% | Feb 28, 2025 |
| Deutsche Bank | Deutsche Bank | Strong Buy Initiates $31 | Strong Buy | Initiates | $31 | +111.03% | Feb 11, 2025 |
| Goldman Sachs | Goldman Sachs | Strong Buy Maintains $45 → $40 | Strong Buy | Maintains | $45 → $40 | +172.29% | Jan 28, 2025 |
| JP Morgan | JP Morgan | Buy Maintains $28 → $24 | Buy | Maintains | $28 → $24 | +63.38% | Jan 7, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $90 → $87 | Strong Buy | Maintains | $90 → $87 | +492.24% | Jan 7, 2025 |
| Baird | Baird | Buy Initiates $31 | Buy | Initiates | $31 | +111.03% | Jan 7, 2025 |
| William Blair | William Blair | Buy Initiates n/a | Buy | Initiates | n/a | n/a | Jan 3, 2025 |
| Stifel | Stifel | Hold → Strong Buy Upgrades $37 | Hold → Strong Buy | Upgrades | $37 | +151.87% | Dec 16, 2024 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.